Terms: = Germ cell tumor AND CASP8, ALPS2B, 841, ENSG00000064012, MGC78473, CAP4, MACH, MCH5, FLICE AND Treatment
74 results:
1. Noscapine and Apoptosis in Breast and Other Cancers.
Calaf GM; Crispin LA; Quisbert-Valenzuela EO
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542508
[TBL] [Abstract] [Full Text] [Related]
2. TNF and IFNγ-induced cell death requires IRF1 and ELAVL1 to promote casp8 expression.
Deng B; Wang J; Yang T; Deng Z; Yuan J; Zhang B; Zhou Z; Chen F; Fang L; Liang C; Yan B; Ai Y
J Cell Biol; 2024 Mar; 223(3):. PubMed ID: 38319288
[TBL] [Abstract] [Full Text] [Related]
3. Structural connectome combining DTI features predicts postoperative language decline and its recovery in glioma patients.
Liu Y; Cui M; Gao X; Yang H; Chen H; Guan B; Ma X
Eur Radiol; 2024 Apr; 34(4):2759-2771. PubMed ID: 37736802
[TBL] [Abstract] [Full Text] [Related]
4. Model incorporating multiple diffusion MRI features: development and validation of a radiomics-based model to predict adult-type diffuse gliomas grade.
Wang P; Xie S; Wu Q; Weng L; Hao Z; Yuan P; Zhang C; Gao W; Wang S; Zhang H; Song Y; He J; Gao Y
Eur Radiol; 2023 Dec; 33(12):8809-8820. PubMed ID: 37439936
[TBL] [Abstract] [Full Text] [Related]
5. Rosmarinic acid decreases viability, inhibits migration and modulates expression of apoptosis-related casp8/CASP3/NLRP3 genes in human metastatic melanoma cells.
da Silva GB; Manica D; da Silva AP; Marafon F; Moreno M; Bagatini MD
Chem Biol Interact; 2023 Apr; 375():110427. PubMed ID: 36863647
[TBL] [Abstract] [Full Text] [Related]
6. Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma.
Cai J; Hu Y; Ye Z; Ye L; Gao L; Wang Y; Sun Q; Tong S; Yang J; Chen Q
Front Immunol; 2022; 13():1011757. PubMed ID: 36325335
[TBL] [Abstract] [Full Text] [Related]
7. PD-1 and CTLA-4 inhibitors in combination vs. alone for the treatment of advanced melanoma: A systematic review and meta-analysis.
He R; Zhao X; Liu J; Zhou Y; Zhang X; Cheng F
Medicine (Baltimore); 2022 Oct; 101(41):e30561. PubMed ID: 36254050
[TBL] [Abstract] [Full Text] [Related]
8. Radiomic study on preoperative multi-modal magnetic resonance images identifies IDH-mutant TERT promoter-mutant gliomas.
Wang H; Zhang S; Xing X; Yue Q; Feng W; Chen S; Zhang J; Xie D; Chen N; Liu Y
Cancer Med; 2023 Feb; 12(3):2524-2537. PubMed ID: 36176070
[TBL] [Abstract] [Full Text] [Related]
9. Analysis of Cancer Survival Associated With Immune Checkpoint Inhibitors After Statistical Adjustment: A Systematic Review and Meta-analyses.
Lin EP; Hsu CY; Berry L; Bunn P; Shyr Y
JAMA Netw Open; 2022 Aug; 5(8):e2227211. PubMed ID: 35976648
[TBL] [Abstract] [Full Text] [Related]
10. Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS-mutant Melanoma.
Schuler M; Zimmer L; Kim KB; Sosman JA; Ascierto PA; Postow MA; De Vos FYFL; van Herpen CML; Carlino MS; Johnson DB; Berking C; Reddy MB; Harney AS; Berlin JD; Amaria RN
Clin Cancer Res; 2022 Jul; 28(14):3002-3010. PubMed ID: 35294522
[TBL] [Abstract] [Full Text] [Related]
11. MRI-based radiomics model can improve the predictive performance of postlaminar optic nerve invasion in retinoblastoma.
Li Z; Guo J; Xu X; Wei W; Xian J
Br J Radiol; 2022 Feb; 95(1130):20211027. PubMed ID: 34826253
[TBL] [Abstract] [Full Text] [Related]
12. Predicting the prognosis of glioma by pyroptosis-related signature.
Chao B; Jiang F; Bai H; Meng P; Wang L; Wang F
J Cell Mol Med; 2022 Jan; 26(1):133-143. PubMed ID: 34816605
[TBL] [Abstract] [Full Text] [Related]
13. Establishment and validation of five autophagy-related signatures for predicting survival and immune microenvironment in glioma.
Zhao Z; Wu Y; Wang Z; Xu J; Wang Y; Zhao Z
Genes Genomics; 2022 Jan; 44(1):79-95. PubMed ID: 34609723
[TBL] [Abstract] [Full Text] [Related]
14. IL13Rα2‑ and EGFR‑targeted pseudomonas exotoxin potentiates the TRAIL‑mediated death of GBM cells.
Karakaş N; Stuckey D; Revai-Lechtich E; Shah K
Int J Mol Med; 2021 Jul; 48(1):. PubMed ID: 34080646
[TBL] [Abstract] [Full Text] [Related]
15. Association of RASSF1A, DCR2, and casp8 Methylation with Survival in Neuroblastoma: A Pooled Analysis Using Reconstructed Individual Patient Data.
Hassan WM; Bakry MS; Siepmann T; Illigens B
Biomed Res Int; 2020; 2020():7390473. PubMed ID: 33381579
[TBL] [Abstract] [Full Text] [Related]
16. Monitoring real-life utilization of pembrolizumab in advanced melanoma using the Portuguese National Cancer Registry.
Borges FC; Ramos C; Ramos A; Mendes GP; Murteira R; Soares P; Furtado C; Miranda AC; Costa FA;
Pharmacoepidemiol Drug Saf; 2021 Mar; 30(3):342-349. PubMed ID: 33103788
[TBL] [Abstract] [Full Text] [Related]
17. Nomograms predict survival outcomes for distant metastatic pancreatic neuroendocrine tumor: A population based STROBE compliant study.
Li G; Tian ML; Bing YT; Wang HY; Yuan CH; Xiu DR
Medicine (Baltimore); 2020 Mar; 99(13):e19593. PubMed ID: 32221079
[TBL] [Abstract] [Full Text] [Related]
18. Dose distribution of the brain tissue associated with cognitive functions in high-grade glioma patients.
Jacob J; Clausse E; Benadjaoud MA; Jenny C; Ribeiro M; Feuvret L; Mazeron JJ; Antoni D; Bernier MO; Hoang-Xuan K; Psimaras D; Carpentier A; Ricard D; Maingon P
Cancer Radiother; 2020 Feb; 24(1):1-10. PubMed ID: 31992516
[TBL] [Abstract] [Full Text] [Related]
19. Comparative-effectiveness of pembrolizumab vs. nivolumab for patients with metastatic melanoma.
Moser JC; Wei G; Colonna SV; Grossmann KF; Patel S; Hyngstrom JR
Acta Oncol; 2020 Apr; 59(4):434-437. PubMed ID: 31920132
[No Abstract] [Full Text] [Related]
20. Evaluation of Combination treatment Effect With TRAIL-secreting Mesenchymal Stem cells and Compound C Against Glioblastoma.
Han HR; Park SA; Ahn S; Jeun SS; Ryu CH
Anticancer Res; 2019 Dec; 39(12):6635-6643. PubMed ID: 31810928
[TBL] [Abstract] [Full Text] [Related]
[Next]
